Thoughts and Suggestions on Calculation of Risk Index in State Sampling Analysis for Quality Evaluation

Abstract

Abstract: In application of the calculation template of risk index in state sampling analysis for quality evaluation, some problems have been identified. For example, we found that it was not very suitable for the calculation of content uniformity and weight variation. By considering these problems, some reasonable suggestions were provided. Related departments were suggested to further perfect the calculation template and to make it more suitable for the state sampling analysis for quality evaluation.

Key words: state sampling analysis for quality evaluation, risk index, risk assessment

CLC Number:

R954

WANG Mei-bo ,SUN Jian, MAO Xiu-Hong, WANG Ke ,JI Shen. Thoughts and Suggestions on Calculation of Risk Index in State Sampling Analysis for Quality Evaluation [J]. Chinese Journal of Pharmacovigilance, 2013, 10(5): 276-277.

[1]	ZAN Ke, ZHAO Lei, JIANG Dacheng, WANG Ying, JIN Hongyu, MA Yu, MA Shuangcheng. Determination of 135 pesticide residues in Farfarae Flos by UPLC-MS/MS and risk assessment [J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 885-890.
[2]	WANG Ran, LI Yifan, LIU Xiaoyan, FENG Xin. One case of pharmaceutical care of drug exposure during pregnancy [J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 933-934.
[3]	WANG Ran, FENG Xin, DU Boran. Advances in risk assessment and pharmaceutical care of pregnancy medication exposure during perinatal period [J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 836-840.
[4]	NIE Lixing, WANG Xinping, LI Jing, DAI Zhong, KANG Shuai, MA Shuangcheng. Content analysis and risk assessment of aristolochic acids in Chinese medicinal materials (decoction pieces) [J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 553-559.
[5]	YAO Keyu, ZHANG Shuqi, JIN Rui, LIU Lihong, ZHU Yan. Comparative study on data set of drug-induced liver injury [J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 568-573.
[6]	NIE Lixing, CHEN Jia, ZHANG Ye, ZHAO Hui, DAI Zhong, MA Shuangcheng. Comprehensive tests and risk assessment of exogenous harmful residues in Isatidis Radix [J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 379-382.
[7]	LI Hailiang, LIU Yuanxi, WANG Zhao, ZAN Ke, WANG Ying, JIN Hongyu, MA Shuangcheng. Transfer behavior and risk assessment of pesticide residue during the processing of Chrysanthemum morifolium [J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1228-1233.
[8]	ZHONG Yingying, WANG Zhao, ZUO Tiantian, LI Yaolei, LI Hailiang, MA Shuangcheng. Research progress on detection and risk assessment of exogenous heavy metals and related elements in Codonopsis Radix [J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1309-1315.
[9]	ZUO Tiantian, WANG Zhao, GUO Yuansheng, WEI Feng, JIN Hongyu, MA Shuangcheng. Non-carcinogenic and carcinogenic risk assessment of toxic elements in Panax quinquefolium L. based on multi-element semi-quantitative screening [J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1108-1112.
[10]	WEN Hairuo, WANG Yanan, JIANG Hua, WANG Xue, WANG Qi, MA Shuangcheng. In vivo genotoxic risk assessment of emodin [J]. Chinese Journal of Pharmacovigilance, 2022, 19(6): 635-640.
[11]	ZHANG Xiaomeng, LYU Jintao, ZHANG Bing, LIN Zhijian, LIU Rongxue. Risk assessment and pre-warning of injection within Bufonis Venenum in the treatment of liver cancer [J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 469-474.
[12]	LI Yaolei, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian, ZAN Ke, JIN Hongyu, MA Shuangcheng. Research on the application of clinical drug-oriented risk assessment method for harmful components of traditional Chinese medicine [J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 475-480.
[13]	ZAN Ke, ZHOU Ying, LI Yaolei, WANG Ying, JIN Hongyu, ZUO Tiantian, MA Shuangcheng. Content determination and health risk assessment of pyrrolizidine alkaloid N-oxides in Vignae Semen [J]. Chinese Journal of Pharmacovigilance, 2022, 19(11): 1186-1190.
[14]	ZHENG Chao, WU Yan, ZHANG Lan, HU Kai, ZENG Ye, WANG Wen, WANG Ling. Methods for risk trend analysis of EU post-marketing surveillance for medical devices [J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 79-82.
[15]	WANG Ying, ZHANG Lei, ZUO Tiantian, SHEN Mingrui, JIN Hongyu, MA Shuangcheng. Formulation and Research of Guidelines for Risk Assessment of Pesticide Residues in Traditional Chinese Medicine [J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 645-648.

Thoughts and Suggestions on Calculation of Risk Index in State Sampling Analysis for Quality Evaluation

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics